Co-Diagnostics, Inc. (NASDAQ:CODX) Q3 2024 Earnings Call Transcript

Co-Diagnostics, Inc. (NASDAQ:CODX) Q3 2024 Earnings Call Transcript November 7, 2024

Co-Diagnostics, Inc. beats earnings expectations. Reported EPS is $-0.32, expectations were $-0.33.

Operator: Good afternoon, and welcome to Co-Diagnostics Third Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I would like now to introduce Andrew Benson, Head of Investor Relations.

Andrew Benson: Good afternoon, everyone. Thank you all for...